CN
2459-10-1
应用筛选条件
关键词:'2459-10-1'
显示 1-5 共 5 条结果 关于 "2459-10-1" 范围 技术文档
Product Information Sheet - T7402
, D. et al., Current Pharmaceutical Design,
1, 95, 1995.
21. Ding, A.H. et al., Science, 248, 370, 1990.
22. Manthey, C.L. et al., J. Immunol., 149, 2459, 1992.
23. Gately, D.P., and Howell, S.B., J
Product Information Sheet - T1912
, D. et al., Current Pharmaceutical Design,
1, 95, 1995.
21. Ding, A.H. et al., Science, 248, 370, 1990.
22. Manthey, C.L. et al., J. Immunol., 149, 2459, 1992.
23. Gately, D.P., and Howell, S.B., J
Data Sheet - G4510
glutathione-agarose is
unaffected by 1% TRITON™ X-100, 1% CTAB,
1% TWEEN®-20, 10 mM DTT, or 0.03% SDS.
2. Add TRITON™ X-100 to a final concentration of
1% (v/v).
3. Centrifuge 10 minutes at 10,000 ×
Reprint: BioProcess International: Accounting for the Donnan Effect in Diafiltration Optimization for High-Concentration UFDF Applications
Sciences
Network unit of EMD Millipore Corp., 900
Middlesex Turnpike Rd., Billerica, MA 01821;
1-781-533-2459;
joshua.arias@emdmillipore.com.
Eprinted and posted with permission to EMD Millipore from
An Update on Ligands for Prostanoid Receptors
M., et al., Br. J. Pharmacol., 122, 217-224 (1997).
53. Bygdeman, M., Danielsson, K.G., Drugs, 62, 2459-2470 (2002).
54. Jones, R.L., et al., Br. J. Pharmacol., 125, 1288-1296 (1998).
55. Gallant, M.